200HO10900 FABULOUS

Print/PDF
Registration Name PROGENESIS FABULOUS-ET
Registration Number HOCAN000012609015
Primary NAAB Code 200HO10900
Secondary Code(s) 777HO10900
Status Inactive
Controller Name Semex Alliance (200)
Date of Birth 8/25/2016
aAa -
DMS -
GFI 12.2%
Genetic Codes * TR TV TL TY TD TP TE
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5C, HH6T, HCD-T
Sire S-S-I MONTROSS JETT-ET
MGS MORNINGVIEW MCC KINGBOY-ET
Beta Casein -
Kappa Casein -
Beta Lactoglobulin -
INDEXES
NM$ 65, 91% R CM$ 63
NM Percentile 18% FM$ 75
GTPI 2732 GM$ 48
PRODUCTION TRAITS
1917 Dtrs 647 herds 7 % US 98% R
Milk 1065 Fat, % 7 , -0.14%
SCS 2.79, 97% R Protein, % 27 , -0.03%
Feed Saved -163 , 59% R Milking Speed 6.49 , 85% R
Health & Fertility
Productive Life 0.3      96% R Mastitis -0.2      91% R
Heifer Livability -1.2       77% R Metritis -0.2      86% R
Livability -3.2      88% R D. Abom 0.2      89% R
DPR -0.2      97% R Ketosis 1.5      84% R
FSC -0.7      96% R R. Placenta -0.3      86% R
HCR -2.1      93% R Milk Fever 0.1      76% R
CCR -1.2      96% R
SCR -        -
DIA 0.4      55% R
RSP 0.5      70% R
Calving Traits
Sire CE 1.4      96% R 1283 Obs
Daughter CE 1.5      96% R 200 Obs, 1190 Dtrs
Sire SB 3.9      94% R 1769 Obs
Daughter SB 3.8      94% R 199 Obs, Dtrs
Gestation Length -0.2      97% R 24 Obs, 234 Dtrs
Early First Calving -2.2      92% R 29 Obs, 91 Dtrs

CDCB August 2026; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2026
1427 Dtrs 526 herds 96% R
PTA Type 1.33 UDC 1.33
HCC 0.59 BWC 0.98
FLC 0.12
Linear Traits
Stature 1.36
Tall
Strength 1.10
Strong
Body Depth 0.90
Deep
Dairy Form 0.24
Open
Rump Angle 0.11
Sloped
Thurl Width -0.48
Sloped
Rear Legs-Side View -0.48
Narrow
Rear Legs-Rear View 0.84
Straight
Foot Angle 1.99
Steep
Feet & Legs Score 0.34
High
F.U. Attachment -2.90
Straight
Rear Udder Height 2.34
High
Rear Udder Width 1.24
Wide
Udder Cleft 0.33
Strong
Udder Depth 0.84
Straight
Front Teat Placement -0.26
Wide
Rear Teat Placement -0.23
Wide
Teat Length 0.01
Long
-2
0
2

CDCB August 2026; Base of Evaluation: HO